Human papillomavirus vaccine acceptability among parents of adolescent girls: Obstacles and challenges in Mysore, India

Preventive Medicine

Volumn 64, Issue , 2014, Pages 69-74

  Madhivanan, Purnima ^a,b   Li, Tan ^a   Srinivas, Vijaya ^b   Marlow, Laura ^c   Mukherjee, Soumyadeep ^a   Krupp, Karl ^a,b  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b Public Health Research Institute of India   (India)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acceptability; Adolescent; Barrier; Correlate; Human papillomavirus; India; School; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CANCER IMMUNIZATION; DAUGHTER; DRUG SAFETY; EXTENDED FAMILY; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; PAIN; PARENTAL ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL ACCEPTANCE; UTERINE CERVIX CANCER; ADULT; ATTITUDE TO HEALTH; CHILD; COMPLICATION; EDUCATIONAL STATUS; EMPLOYMENT; MALE; MARRIAGE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PARENT; PARENTAL CONSENT; PATIENT ATTITUDE; PSYCHOLOGY; RELIGION; SCHOOL HEALTH SERVICE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADOLESCENT; ADULT; CHILD; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INDIA; LOGISTIC MODELS; MALE; MARITAL STATUS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTAL CONSENT; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; RELIGION; SCHOOL HEALTH SERVICES; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84899700903     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.04.002     Document Type: Article

References (37)

1. Allen J.D., Coronado G.D., Williams R.S., et al. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010, 28(24):4027-4037.
2. Alsaad M.A., Shamsuddin K., Fadzil F. Knowledge towards HPV infection and HPV vaccines among Syrian mothers. Asian Pac. J. Cancer Prev. 2012, 13:879-883.
3. Bartolini R.M., Winkler J.L., Penny M.E., LaMontagne D.S. Parental acceptance of HPV vaccine in Peru: a decision framework. PLoS ONE 2012, 7(10):e48017.
4. Basu P., Mittal S. Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India. J. Obstet. Gynaecol. Res. 2011, 37(5):393-401.
5. Becker-Dreps S., Otieno W.A., Brewer N.T., Agot K., Smith J.S. HPV vaccine acceptability among Kenyan women. Vaccine 2010, 28(31):4864-4867.
6. Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev. Med. 2007, 45(2):107-114.
7. Canfell K., Sitas F., Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med. J. Aust. 2006, 185(9):482.
8. Census 2011 [Internet] Available from:. http://censusindia.gov.in/.
9. Cervical cancer, human papillomavirus (HPV), HPV vaccines Key points for policy-makers and health professionals [Internet] Available from:. http://www.searo.who.int/LinkFiles/Publications_Cervical_Cancer_HPV.pdf.
10. Cohen S.A. A long and winding road: getting the HPV vaccine to women in the developing world. Guttmacher Policy Rev. 2007, 10(3).
11. DiAngi Y.T., Panozzo C.A., Ramogola-Masire D., Steenhoff A.P., Brewer N.T. A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS ONE 2011, 6(10):e25481.
12. Dikshit R., Gupta P.C., Ramasundarahettige C., et al. Cancer mortality in India: a nationally representative survey. Lancet 2012, 379(9828):1807-1816.
13. Downs L.S., Smith J.S., Scarinci I., Flowers L., Parham G. The disparity of cervical cancer in diverse populations. Gynecol. Oncol. 2008, 109(2):S22-S30.
14. El-Khatiba Z., Tota J.E., Kaufmann A.M. Progress on human papillomavirus (HPV) infection and cervical cancer prevention in sub-Saharan Africa: highlights of the 27th International Papillomavirus Conference in Berlin, 17-22 September 2011. J. Epidemiol. Glob. Health 2012, 2(2):99-102.
15. Feinberg M. HPV vaccine suspension in India. Lancet 2010, 376(9753):1644-1645.
16. Fernández M.E., Allen J.D., Mistry R., Kahn J.A. Integrating clinical, community, and policy perspectives on HPV vaccination. Annu. Rev. Public Health 2010, 31:235.
17. Glanz K., Rimer B.K., Viswanath K. Health Behavior and Health Education: Theory, Research, and Practice 2008, John Wiley & Sons.
18. HPV vaccination [Internet] Available from:. http://www.nhs.uk/conditions/hpv-vaccination/pages/introduction.aspx?WT.mc_id=090805.
19. HPV vaccine - questions &, answers [Internet] Available from:. http://www.cdc.gov/vaccines/vpd-vac/hpv/vac-faqs.htm.
20. Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J. Med. Paediatr. Oncol. 2012, 33(1):7.
21. Kohler C.L., Grimley D., Reynolds K. Theoretical approaches guiding the development and implementation of health promotion programs. Handbook of Health Promotion and Disease Prevention 1999, 23-49. Kluwer Academic/Plenum Publishers, New York, NY.
22. Krupp K., Marlow L.A., Kielmann K., et al. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India. J. Adolesc. Health 2010, 46(4):379-384.
23. Madhivanan P., Krupp K., Yashodha M., Marlow L., Klausner J.D., Reingold A.L. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India. Vaccine 2009, 27(38):5203-5208.
24. Marlow L.A., Waller J., Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007, 25(11):1945-1952.
25. Marlow L.A., Forster A.S., Wardle J., Waller J. Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. J. Adolesc. Health 2009, 44(5):446-451.
26. Sam I., Wong L., Rampal S., et al. Maternal acceptance of human papillomavirus vaccine in Malaysia. J. Adolesc. Health 2009, 44(6):610-612.
27. Sane vax inc.letter concerning gardasil [Internet] updated Sept 22. Available from:. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2011/09/WC500112851.pdf.
28. Singhal T., Amdekar Y., Agarwal R., et al. Consensus recommendations on immunization, 2008. Indian Pediatr. 2008, 45(8):635-648.
29. Srinivasan S. HPV vaccine trials and sleeping watchdogs. Indian J. Med. Ethics 2011, 8(2).
30. Tricco A.C., Anonychuk A.M., Ng C., Pham B. International acceptability of human papillomavirus vaccines: a systematic review. Nov 2-Nov 10; Beijing, China. 24th International Papillomavirus Conference and Clinical Workshop 2007.
31. Trim K., Nagji N., Elit L., Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet. Gynecol. Int. 2012, 2012:921236. 10.1155/2012/921236.
32. Vedantham H., Silver M.I., Kalpana B., et al. Determinants of VIA (visual inspection of the cervix after acetic acid application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Cancer Epidemiol. Biomark. Prev. 2010, 19(5):1373-1380.
33. Verma R., Khanna P. Human papilloma virus vaccines: need to be introduced in India. Human Vaccines Immunother. 2013, 9(1):97-99.
34. Waller J., Marlow L.A., Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol. Biomark. Prev. 2006, 15(7):1257-1261.
35. Witte K. Predicting risk behaviors: development and validation of a diagnostic scale. J. Health Commun. 1996, 1(4):317-342.
36. World Health Organization Information Sheet: Observed Rate of Vaccine Reactions Human Papilloma Virus Vaccine 2012.
37. World Health Organization, UNICEF, UNFPA, The World Bank Trends in maternal mortality: 1990 to 2010. WHO, UNICEF, UNFPA and the World Bank Estimates 2012.